additional postive action needs to be taken , page-2

I agree with most of the sentiment here. The old board needs to go. A separate scientific committee should be established and a distance from NN be maintained.

The potential product appears to be great. If properly marketed (and it hasn't been so far) then a medium term deal with a major pharma should be readily obtained. Would be interested to find our what trials need to be undertaken to determine correct dosing and delivery vector.

The past dealings with NN have been too cosy and in my view to the detriment of shareholders value.

The AGM should be interesting. Will definitely be attending. Overall I am now much more positive about the company.

Finally, I would like to extend my support and appreciation to the Substantial Shareholders Group that have achieved a lot so far.